08:23 AM EDT, 09/23/2025 (MT Newswires) -- (Updates with Kenvue's ( KVUE ) response from fourth paragraph onward and stock price movement.)

US President Donald Trump on Monday urged pregnant women to avoid taking acetaminophen, the active ingredient in Kenvue's ( KVUE ) Tylenol drug, saying it can be associated with a "very increased" risk of autism, news outlets reported.

"They are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary," such as for fever treatment, "if you can't tough it out," CNN reported, citing Trump.

In a Tuesday report, Bloomberg said a number of health experts criticized Trump's remarks, with the American College of Obstetricians and Gynecologists referring to the statement as "irresponsible." According to the report, Trump's remarks disregard years of evidence and could endanger pregnant women and their babies.

Kenvue ( KVUE ) confirmed in a e-mail statement to MT Newswires that the drug does not cause autism.

"We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned about the health risks and confusion this poses for expecting mothers and parents," a Kenvue ( KVUE ) spokesperson said.

"Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy. Without it, women face dangerous choices: suffer through conditions like fever that are potentially harmful to both mom and baby or use riskier alternatives. High fevers and pain are widely recognized as potential risks to a pregnancy if left untreated," the spokesperson added.

Kenvue ( KVUE ) said it will continue advising pregnant women to consult health professionals before taking any over-the-counter medication.

The company's shares were up nearly 6% in recent Tuesday premarket activity.